APSR2026-70

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP03-004
P76
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1202825-46904-APSR IPSS CPAP HT Octobre 2026_429276.pdf
Format: PDF Only
10. Respiratory Neurobiology and Sleep
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

An Emmanuel Le * Wong Tai Sin Hospital Department of Tuberculosis and Chest Kowloon Hong Kong
Sze Man Wong - Private Practice Private Practice Hong Kong Hong Kong
Chu Yip Ng - Kwong Wah Hospital Department of Medicine and Geriatrics Kowloon Hong Kong
Cee Zhung Steven Tseng - Wong Tai Sin Hospital Department of Tuberculosis and Chest Kowloon Hong Kong
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
An Emmanuel
Le
Le_an_md@yahoo.com
+85256491223
41-50
 
Original Research
The Effect of Continuous Positive Airway Pressure (CPAP) in controlled hypertension patients with lower urinary tract symptoms (LUTS) at 6 months.
Maximum 25 words
Abstract Content
Hypertension is associated with a 1.2-fold to 1.3-fold higher risk of nocturia (Rahman SN et Al,Journal of Urology. 2021 Jun 1 ;205(6):1577–83.). Sleep apnoea is associated with an increase likelihood of nocturia (Fantus RJ et Al, J Urol. 2018 Jul;200(1):161-166.). And the International Prostate Symptoms Score (IPSS) has been validated in Hong Kong for male and female subjects for LUTS.(Choi, E.P. et Al,Health Qual Life Outcomes 12, 1 (2014). This study aimed to assess the IPSS after CPAP titration and at 6 months in patients with controlled hypertension.
Patients referred for sleep studies were recruited from 15/02/2025 to 30/05/2025. The International Prostate Symptom Score (IPSS) has been validated to evaluate LUTS in female and male patients locally (Choi, E.P. et Al,Health Qual Life Outcomes 12, 1 (2014)), and IPSS was assessed before, after CPAP titration and 6 months after initiation of CPAP. The minimal clinically important difference is ≥ 25% (Babar M et Al, Cent European J Urol. 2024;77(2):262-272.).
A total of 56 patients were recruited and followed at 6 months. Except the difference in age, patients’ characteristics are overall the same (ESS, BMI, neck circumference, blood pressure, AHI, ODI, IPSS before and after use of CPAP). The reduction of IPSS after CPAP titration and at 6 months is statistically significant in both groups. However, the comparison of IPSS between both group was not significant.
Comparing to non-hypertensive patients, patients with controlled hypertension had their IPSS improved on early CPAP initiation, though it did not reach statistical significance. However, at 6 months, the CPAP effect showed no difference between both groups. CPAP may not play a role in the reduction of IPSS in controlled hypertensive patients. In addition, CPAP at 6 months achieved the MCID of 25%. Further studies with larger samples would be necessary.
 
 
 
 
 
Yes
Yes
https://storage.unitedwebnetwork.com/files/1285/1202825-37089-TableAPSR2006IPSS_364519.jpg
JPG or JPEG or PNG format ONLY
Sleep apnea, hypertension, lower urinary tract symptoms
maximum 3 keywords and no abbreviations, separated by commas
All authors declare that they have no conflicts of interest.
315